How long does 4-AcO-MET last?

The total duration of 4-AcO-MET via oral is 4 hours to 6 hours. Onset typically occurs within 20 minutes to 1 hour. Peak effects last 1 hour to 2 hours.

4-AcO-MET — SubstanceWiki

4-AcO-MET (4-acetoxy-N-methyl-N-ethyltryptamine) is a synthetic psychedelic tryptamine belonging to the acetylated psilocybin analog family. It functions as a prodrug that is rapidly hydrolyzed by serum esterases to 4-HO-MET (4-hydroxy-MET, metocin), the presumed primary active form. Structurally, 4-AcO-MET is the N-methyl/N-ethyl analog of psilocybin — occupying a position on the tryptamine substitution spectrum between 4-AcO-DMT (dimethyl) and 4-AcO-DET (diethyl).

Community reports characterize 4-AcO-MET as a distinctly visual and aesthetic tryptamine with a character somewhat lighter and more manageable than 4-AcO-DMT at comparable doses. Users frequently describe vivid, colorful open-eye visuals, a euphoric emotional baseline, and music enhancement that is particularly pronounced. Reddit users have described the experience as combining some of the warmth and openness of the broader 4-AcO compound family with a somewhat playful character. The combination with dissociatives such as O-PCE has been documented in community trip reports, though such combinations carry additional risk.

The compound occupies a legal gray zone in most jurisdictions and circulates primarily through the research chemical market. Human pharmacokinetic data is essentially absent from the peer-reviewed literature, and the compound's safety profile is inferred from structural analogy to psilocybin and community-accumulated experience rather than formal clinical study.

How It Feels

The onset of 4-AcO-MET is brisk and cheerful by psychedelic standards. Within fifteen to twenty-five minutes of ingestion, a wave of warmth and tingling washes upward from the stomach through the chest and into the face. Mild nausea may flicker briefly but rarely lingers. Almost immediately, color saturation begins to climb — the world becomes a more vivid version of itself, as though someone has adjusted the hue and brightness controls on reality. Greens become electric, blues deepen to sapphire, and every surface seems to glow with an inner luminescence. There is an early burst of euphoria, a buoyant lightness that lifts mood and loosens the muscles.

The come-up accelerates rapidly, reaching full intensity within sixty to ninety minutes. Visuals are the headline act: surfaces flow and morph with intricate, colorful geometry that has a distinctly playful character. Patterns tend toward the ornate and organic — swirling Art Nouveau flourishes, flowing paisleys, and kaleidoscopic mandalas that shift in real time. Colors bleed and merge in ways that feel celebratory rather than disorienting. Open-eye visuals are vivid enough to be captivating but rarely so overwhelming that functional perception is compromised. Closed-eye visuals are extraordinary — vast, luminous landscapes of impossible color and geometric complexity. Music is deeply enhanced, each note arriving with emotional weight and visual accompaniment.

The headspace of 4-AcO-MET is remarkably clear and manageable compared to many tryptamines. Thought flows freely and creatively without the heavy introspective undertow of psilocin or the looping tangentiality of LSD. Conversations remain accessible, humor is amplified, and there is a persistent sense of delight that pervades the experience. The body feels good — warm, relaxed, and gently energized. Touch is subtly enhanced, and there is a mild empathogenic quality that makes social interaction feel easy and rewarding.

The peak lasts roughly two hours before beginning a smooth, comfortable descent. The vivid geometry softens to a gentle shimmer, the colors gradually return toward their natural values, and the euphoria settles into a contented calm. The total duration is typically four to five hours — shorter than most classical psychedelics — and the comedown leaves behind a warm afterglow of heightened color perception and quiet happiness. Sleep comes relatively easily afterward, often accompanied by vivid, pleasant dreams.

Subjective Effects

The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.

Physical Effects

Physical(12)

Excessive yawning— Involuntary, repeated yawning that occurs far more frequently than normal and often without the usua...
Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
Muscle relaxation— The experience of muscles throughout the body losing their rigidity and tension, becoming noticeably...
Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
Runny nose— Excessive nasal discharge commonly occurring during opioid withdrawal or from nasal irritation cause...
Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Teeth grinding— An involuntary clenching and rhythmic grinding of the jaw muscles, known clinically as bruxism, that...
Watery eyes— Excessive tear production causing overflow tearing and blurred vision, commonly occurring during opi...

Cognitive & Perceptual Effects

Visual(13)

After images— A visual phenomenon in which a faint, ghostly imprint of a previously viewed image persists in the v...
Colour enhancement— An intensification of the brightness, vividness, and saturation of colors in the external environmen...
Colour shifting— The visual experience of colors on objects and surfaces cycling through continuous, fluid transforma...
Drifting— The visual experience of perceiving stationary objects, textures, and surfaces as appearing to flow,...
Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
Internal hallucination— Vivid, detailed visual experiences perceived within an imagined mental landscape that can only be se...

Detection Methods

Urine Detection

4-AcO-MET is not targeted by standard immunoassay-based urine drug screens. As a prodrug, 4-AcO-MET is rapidly hydrolyzed in vivo to its corresponding 4-HO (psilocin-type) metabolite, and it is primarily this metabolite that would be detected in biological specimens. Specialized LC-MS/MS methods can detect 4-substituted tryptamine metabolites in urine for approximately 24 to 48 hours after ingestion. The detection window is relatively short compared to many other drug classes due to the rapid hepatic metabolism and renal clearance of tryptamine compounds. Psilocin (4-HO-DMT) is the most commonly targeted analyte in specialized tryptamine panels, and structural analogs may or may not be captured depending on the specific method.

Blood and Serum Detection

Blood detection windows for 4-AcO-MET are short, typically 4 to 12 hours after oral ingestion. Peak plasma concentrations of the active metabolite occur within 1 to 2 hours. The rapid first-pass metabolism means that parent compound concentrations in blood are often negligible for 4-AcO prodrugs, while 4-HO compounds themselves are measured directly. LC-MS/MS is required for reliable serum detection at the low concentrations involved.

Standard Drug Panel Inclusion

4-AcO-MET is NOT included on standard 5-panel, 10-panel, or 12-panel drug screens. Tryptamines do not cross-react with immunoassay targets for any of the standard panel analytes (amphetamines, cannabinoids, cocaine metabolites, opiates, PCP, benzodiazepines, or barbiturates). Detection requires a specific request for tryptamine or novel psychoactive substance testing at a reference laboratory. Some extended forensic panels include psilocin, which may capture certain 4-substituted tryptamines, but this coverage is not guaranteed for all structural variants.

Confirmatory Methods

Confirmatory identification of 4-AcO-MET relies on LC-MS/MS with reference standards specific to the compound or its expected metabolites. GC-MS can also be used following appropriate derivatization. Immunoassay-based methods for psilocybin and psilocin exist but show variable cross-reactivity with structural analogs and are not considered reliable for novel 4-substituted tryptamines. Reference laboratories specializing in novel psychoactive substances offer the most comprehensive detection capabilities.

Reagent Testing (Harm Reduction)

The Ehrlich reagent is the primary harm reduction tool for 4-AcO-MET. A sample placed on the reagent should produce a purple to violet color change, confirming the presence of an indole ring system characteristic of tryptamines. This reaction is shared with LSD, psilocybin, DMT, and all indole-containing compounds, so it confirms the general class but not the specific identity. The Hofmann reagent provides a confirmatory blue to violet reaction for tryptamines. The Marquis reagent typically shows no reaction or a dark brown discoloration with 4-substituted tryptamines. A positive Ehrlich result significantly reduces the probability that the substance is a dangerous substitute such as an NBOMe compound.

Interactions

Substance	Status	Note
3-FMA	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-MMC	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
8-Chlorotheophylline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Adrafinil	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Anandamide	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
APICA	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Atropa belladonna	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Benzydamine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Bromantane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabidiol	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Datura	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Dichloropane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Diphenhydramine	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Ephedrine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Harmala alkaloid	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Hexedrone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methcathinone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Nicotine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Oxiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Peganum harmala	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Phenylpiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Rhodiola Rosea	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabis	Uncertain	—
1,3-Butanediol	Low Risk & Synergy	Cross-tolerance exists; effects compound
25E-NBOH	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-2	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-21	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-7	Low Risk & Synergy	Cross-tolerance exists; effects compound
3-Cl-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCMo	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
4-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
Allylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ayahuasca	Low Risk & Synergy	Cross-tolerance exists; effects compound
Deschloroketamine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Diphenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
DOM	Low Risk & Synergy	Cross-tolerance exists; effects compound
DPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
Efavirenz	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ephenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
EPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
HXE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Ibogaine	Low Risk & Synergy	Cross-tolerance exists; effects compound
Inhalants	Low Risk & Synergy	Produces unique synergistic effects; often combined
Memantine	Low Risk & Synergy	Produces unique synergistic effects; often combined
MET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Methallylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
MiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MXiPr	Low Risk & Synergy	Produces unique synergistic effects; often combined
O-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Psilocybin Mushrooms	Low Risk & Synergy	Cross-tolerance exists; effects compound
Lorazepam	Low Risk & Decrease	Depressants dull psychedelic effects; benzodiazepines are commonly used as trip-killers

Showing 60 key interactions out of 79 total.

Toxicity & Safety

Overview

No formal toxicological studies specific to 4-AcO-MET have been conducted in humans. Its toxicity profile is extrapolated from structural analogy to psilocybin and 4-AcO-DMT, both of which demonstrate very low acute physiological toxicity. No documented fatalities attributable specifically to 4-AcO-MET have been identified.

Physiological Effects

Standard serotonergic sympathomimetic effects: pupil dilation, mild tachycardia, modest blood pressure elevation, nausea during onset (particularly on a full stomach). These are generally transient and self-limiting. Occasionally, nausea can progress to vomiting during the onset phase.

Psychological Risks

Anxiety and difficult experiences — As with all psychedelic tryptamines; dose-dependent and highly context-sensitive.
Psychosis trigger — Absolute contraindication in individuals with personal or family history of schizophrenia or psychotic disorders.
Disinhibition and decision-making impairment — Community reports of combinations with dissociatives (O-PCE) highlight the increased cognitive impairment and unpredictability inherent in polydrug psychedelic sessions.
HPPD — Rare but possible; the risk of persisting perceptual disturbances following any 5-HT2A agonist psychedelic should not be dismissed.

Drug Interactions

MAOIs — Potentiation; serotonin syndrome risk; avoid.
Lithium — Contraindicated; seizure risk.
Dissociatives (ketamine, DCK, O-PCE) — Can profoundly intensify and destabilize the experience; significantly higher risk of overwhelming or disorienting effects. Reddit reports document such combinations going both remarkably and severely.
Cannabis — Unpredictable intensity amplification.

Addiction Potential

not habit-forming

Overdose Information

Fatal overdose from 4-AcO-MET alone, at doses within the typical recreational range, is extremely unlikely based on the available evidence for classical psychedelics. The therapeutic index for most psychedelics is very wide.

However, psychological emergencies can occur and require appropriate response:

Severe anxiety, panic, or psychotic episodes
Dangerous behavior due to impaired reality testing
Self-harm in the context of a distressing experience

Emergency management: If someone is experiencing a severe adverse reaction, move them to a calm, quiet environment. Speak reassuringly. Do not restrain unless there is immediate danger. Benzodiazepines (if available and the person is conscious and able to swallow) can reduce acute anxiety. If psychotic symptoms, self-harm risk, or medical distress is present, seek emergency medical attention.Medical attention: Seek help immediately for seizures, extremely elevated body temperature, signs of serotonin syndrome (agitation, tremor, diarrhea, rapid heart rate), or if the substance consumed is uncertain.

Full	almost immediately after ingestion
Half	3 days
Zero	7 days

4-AcO-MET

Quick Dosage

Dosage

oral

Duration

oral

How It Feels

Subjective Effects

Physical Effects

Physical(12)

Cognitive & Perceptual Effects

Visual(13)

Pharmacology

Prodrug Mechanism

Receptor Pharmacology

Pharmacokinetics

Tolerance

Detection Methods

Urine Detection

Blood and Serum Detection

Standard Drug Panel Inclusion

Confirmatory Methods

Reagent Testing (Harm Reduction)

Interactions

History

Synthesis and Documentation

Research Chemical Emergence

Community Development

Legal Status

Harm Reduction

Source and Test

Dosing

Combinations to Avoid

Set and Setting

If Needed: Abort

Toxicity & Safety

Overview

Physiological Effects

Psychological Risks

Drug Interactions

Addiction Potential

Overdose Information

Tolerance

Cross-tolerances

Legal Status

Experience Reports (2)

Tips (6)

Community Discussions (2)

See Also

References (4)

Frequently Asked Questions

Cognitive(16)

Transpersonal(2)